Cotsiranib

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name

Cotsiranib

DrugBank Accession Number

DB18404

Background

Not Available

Type

Biotech

Groups

Investigational

Biologic Classification

Gene Therapies
Other gene therapies

Synonyms

STP705 (small interfering RNA (siRNA) therapeutic directed against transforming growth factor-beta 1 (TGF-beta 1) and cyclo-oxygenase-2 (COX-2))

External IDs

Indication: Not Available
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings: Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics: Not Available
Mechanism of action: Not Available
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Not Available
Half-life: Not Available
Clearance: Not Available
Adverse Effects: Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity: Not Available
Pathways: Not Available
Pharmacogenomic Effects/ADRs: Not Available

Drug Interactions: This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions: Not Available

Clinical Trials

Phase	Status	Purpose	Conditions	Count
2	Active Not Recruiting	Treatment	Basal Cell Carcinoma (BCC)	1
2	Active Not Recruiting	Treatment	Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)	1
2	Active Not Recruiting	Treatment	Keloids Scars	1
1	Active Not Recruiting	Treatment	Cholangiocarcinoma / Hepatic Metastases / Hepatocellular Carcinoma	1
1	Active Not Recruiting	Treatment	Obesity, Abdominal	1
1, 2	Active Not Recruiting	Treatment	Facial isSCC	1
1, 2	Completed	Treatment	Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)	1
1, 2	Completed	Treatment	Scars, Hypertrophic	1
1, 2	Not Yet Recruiting	Treatment	Scars, Hypertrophic	1

Drug created at September 21, 2023 22:14 / Updated at September 24, 2023 02:56